ES2115665T3 - Derivado de triterpeno. - Google Patents

Derivado de triterpeno.

Info

Publication number
ES2115665T3
ES2115665T3 ES92900597T ES92900597T ES2115665T3 ES 2115665 T3 ES2115665 T3 ES 2115665T3 ES 92900597 T ES92900597 T ES 92900597T ES 92900597 T ES92900597 T ES 92900597T ES 2115665 T3 ES2115665 T3 ES 2115665T3
Authority
ES
Spain
Prior art keywords
hydrogen
triterpen
derived
formula
antiendotheline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92900597T
Other languages
English (en)
Inventor
Masafumi Fujimoto
Kensuke Sakurai
Shinichi Mihara
Miharu Nakamura
Toshiro Konoike
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of ES2115665T3 publication Critical patent/ES2115665T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

UN DERIVADO DEL TRITERPENO REPRESENTADO POR LA FORMULA GENERAL (I), QUE TIENE UNA ACTIVIDAD ANTIENDOTELINA Y ES UTIL EN LA PREVENCION Y EL TRATAMIENTO DE ENFERMEDADES DEL SISTEMA CARDIOVASCULAR, Y SU COMPOSICION FARMACEUTICA. EN LA FORMULA (I), R1 REPRESENTA HIDROGENO O UN RESIDUO DE ESTER METABOLICO; R3 REPRESENTA UN ARILO O UN GRUPO HETEROCICLICO AROMATICO QUE SE PUEDE SUBSTITUIR; UNA DE LAS X E Y ES HIDROXI Y LA OTRA ES HIDROGENO, O ALTERNATIVAMENTE X E Y SE COMBINAN ENTRE SI PARA REPRESENTAR OXO; Y Z REPRESENTA OXIGENO O DOS ATOMOS DE HIDROGENO.
ES92900597T 1991-01-29 1991-12-13 Derivado de triterpeno. Expired - Lifetime ES2115665T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2937291 1991-01-29

Publications (1)

Publication Number Publication Date
ES2115665T3 true ES2115665T3 (es) 1998-07-01

Family

ID=12274319

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92900597T Expired - Lifetime ES2115665T3 (es) 1991-01-29 1991-12-13 Derivado de triterpeno.

Country Status (8)

Country Link
US (1) US5248807A (es)
EP (1) EP0526642B1 (es)
JP (1) JP2950616B2 (es)
AT (1) ATE164588T1 (es)
DE (1) DE69129193T2 (es)
DK (1) DK0526642T3 (es)
ES (1) ES2115665T3 (es)
WO (1) WO1992012991A1 (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) * 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5736509A (en) * 1990-12-14 1998-04-07 Texas Biotechnology Corporation Cyclic peptide surface feature mimics of endothelin
WO1993023404A1 (en) * 1992-05-19 1993-11-25 Immunopharmaceutics, Inc. Compounds that modulate endothelin activity
US5352800A (en) * 1993-03-11 1994-10-04 Merck & Co., Inc. Process for the production of a novel endothelin antagonist
US5767310A (en) * 1993-03-19 1998-06-16 Merck & Co., Inc. Phenoxyphenylacetic acid derivatives
US5334598A (en) * 1993-03-19 1994-08-02 Merck & Co., Inc. Six-membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives
US5420133A (en) * 1993-03-19 1995-05-30 Merck & Co., Inc. Quinazolinones substituted with phenoxyphenylacetic acid derivatives
US5374638A (en) * 1993-03-19 1994-12-20 Merck & Co., Inc. Six membered ring fused imidazoles substituted with phenoxyphenylacetic acid derivatives used to treat asthma
US5401745A (en) * 1993-03-19 1995-03-28 Merck & Co., Inc. Quinazolinones substituted with phenoxyphenylacetic acid derivatives
US5527890A (en) * 1993-04-16 1996-06-18 Glycomed Incorporated Derivatives of triterpenoid acids and uses thereof
CA2121724A1 (en) * 1993-04-21 1994-10-22 Toshifumi Watanabe Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
ES2094622T3 (es) * 1993-06-11 1997-01-16 Shionogi & Co Derivados triterpenos y antagonistas del receptor de endotelina que los contiene.
US5686478A (en) * 1993-07-20 1997-11-11 Merck & Co. Inc. Endothelin antagonists
CN1034334C (zh) * 1993-08-14 1997-03-26 贵州省中医研究所 齐酞酸钠及其药物组合物
US5492917A (en) * 1993-09-29 1996-02-20 Merck & Co., Inc. Endothelin antagonists incorporating a cyclobutane
US5538991A (en) * 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides
US5559135A (en) * 1994-09-14 1996-09-24 Merck & Co., Inc. Endothelin antagonists bearing pyridyl amides
ES2202449T3 (es) * 1995-06-02 2004-04-01 SHIONOGI & CO., LTD. Inhibidor de edema cerebral.
US5977117A (en) 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5958905A (en) * 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
SG100767A1 (en) 1997-04-28 2003-12-26 Texas Biotechnology Corp Sulfonamides for treatment of endothelin-mediated disorders
US5783705A (en) 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
US7566452B1 (en) 1999-05-04 2009-07-28 New York University Cancer treatment with endothelin receptor antagonists
NZ519717A (en) 1999-12-31 2003-06-30 Texas Biotechnology Corp Sulfonamides and derivatives thereof that modulate the activity of endothelin
WO2003080643A1 (fr) * 2002-03-22 2003-10-02 Shionogi & Co., Ltd. Procede de production de derives de triterpenes
US20050175667A1 (en) * 2004-02-10 2005-08-11 Wenda Carlyle Use of endothelin antagonists to prevent restenosis
US8017793B2 (en) 2004-05-14 2011-09-13 Shionogi & Co., Ltd. Oxidation of alcohol with use of hydrogen peroxide and tungsten catalyst
DE602005026993D1 (de) * 2004-12-21 2011-04-28 Dow Global Technologies Inc Klebstoffzusammensetzung auf polypropylenbasis
US20070207989A1 (en) * 2006-03-03 2007-09-06 Savipu Pharmaceuticals Diterpene derivatives for the treatment of cardiovascular, cancer and inflammatory diseases
US7795306B2 (en) * 2006-03-03 2010-09-14 Inderjit Kumar Dev Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of NF-κB
US7323476B2 (en) * 2006-03-03 2008-01-29 Savipu Pharmaceuticals Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases
RU2008136315A (ru) * 2006-03-13 2010-04-20 Инсайсив Фармасьютикалз, Инк. (US) Композиции ситаксентана натрия
MX2008011842A (es) * 2006-03-13 2008-10-02 Encysive Pharmaceuticals Inc Procedimientos y composiciones para el tratamiento de insuficiencia cardiaca diastolica.
US20070243273A1 (en) * 2006-04-12 2007-10-18 Savipu Pharmaceuticals Reduction of the Deleterious Effects of Tobacco Smoking
US20080026061A1 (en) * 2006-06-22 2008-01-31 Reichwein John F Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide
US20080017207A1 (en) * 2006-07-18 2008-01-24 Savipu Pharmaceuticals Reduction of the Deleterious Effects of Tobacco Smoking by the Induction of Phase 2 Enzymes by Nerf2
US20080187608A1 (en) * 2007-02-05 2008-08-07 Savipu Pharmaceuticals Enriched fractions from clary sage for the treatment of cancer, cardiovascular and inflammatory diseases
US20090022821A1 (en) * 2007-07-17 2009-01-22 Inderjit Kumar Dev Compositions from wax myrtle for the treatment of cancer, cardiovascular and inflammatory diseases
TWI492745B (zh) 2008-01-11 2015-07-21 Reata Pharmaceuticals Inc 合成的三萜系化合物及其使用於治療疾病之方法
JP5529850B2 (ja) 2008-04-18 2014-06-25 リアタ ファーマシューティカルズ インコーポレイテッド 抗酸化炎症モジュレーター：ｃ環中に飽和を有するオレアノール酸誘導体
CN103342729B (zh) * 2013-03-26 2016-09-14 中国科学院上海药物研究所 咖啡酰基取代的五环三萜类衍生物及其用途
KR102486434B1 (ko) 2016-11-08 2023-01-09 리아타 파마슈티컬즈 홀딩스, 엘엘씨 바독솔론 메틸 또는 이의 유사체를 사용하는 알포트 증후군의 치료 방법
BR112020009867A2 (pt) 2018-01-04 2020-11-03 Amryt Research Limited composição formadora de cremosidade

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI77669C (fi) * 1983-04-13 1989-04-10 Ciba Geigy Ag 20-spiroxaner och analoger, som innehaoller en oeppen ring e, foerfarande foer deras framstaellning samt dessa innehaollande farmaceutiska preparat.
JPS63222119A (ja) * 1987-03-10 1988-09-16 Rooman Kogyo:Kk 肝臓疾患用剤
US4997836A (en) * 1988-11-11 1991-03-05 Takeda Chemical Industries, Ltd. Trisubstituted piperazine compounds, their production and use

Also Published As

Publication number Publication date
US5248807A (en) 1993-09-28
EP0526642A1 (en) 1993-02-10
DK0526642T3 (da) 1998-10-19
EP0526642A4 (es) 1994-02-09
JP2950616B2 (ja) 1999-09-20
ATE164588T1 (de) 1998-04-15
DE69129193D1 (en) 1998-05-07
EP0526642B1 (en) 1998-04-01
DE69129193T2 (de) 1998-07-30
WO1992012991A1 (en) 1992-08-06

Similar Documents

Publication Publication Date Title
ES2115665T3 (es) Derivado de triterpeno.
ES2194986T3 (es) Compuestos de carbonil-piperazinilo y piperidinilo que inhiben la farnesil-protein-transferasa.
ES2073889T3 (es) Composicion despigmentante que contiene unos derivados de arbutosido.
IL109526A0 (en) Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
NO972156L (no) 2-cyanacrylsyre-estere
NZ240676A (en) Heterocyclic compounds substituted by a (piperidin-4-yl)-1-oxoalkyl group and pharmaceutical compositions thereof
ATE16488T1 (de) M-4- und isom-4-derivate, ihre herstellung und diese enthaltende zusammensetzungen.
IT1229570B (it) Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
ZA911728B (en) Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors
IL88848A0 (en) Immunoassays utilizing chemiluminescent esters,thioesters and amides as the labels
IT1229569B (it) Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
ES2007543A6 (es) Procedimiento de preparacion de 1,4-dihidropiridinas.
DE69119875T2 (de) Verwendung von Dioxabicyclo [3.3.0]octane Derivaten zur Herstellung eines Arzneimittels zur Hemmung des Cholesterinmetabolismus.
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
TR199902350T2 (xx) Yeni piridin t�revleri ve onlardan olu�an farmakotik bile�imler.
MX9300203A (es) Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene.
ATE113293T1 (de) Biaromatische ester von makroliden antibiotika und linkosamiden antibiotika, verfahren zu ihren herstellung und die sie enthaltenden pharmazeutischen und kosmetischen zusammensetzungen.
ATE70050T1 (de) 1-benzoyl-2-oxo-5-alkoxy-pyrrolidin-derivate, ihre herstellung und verwendung als heilmittel und zubereitungen, die sie enthalten.
ES2080445T3 (es) Derivados de ursano, su preparacion y formulaciones farmaceuticas de los mismos.
JPS6422852A (en) Novel derivative of 1-arylsulfonyl-1,5-dihydro- 2h-pyrrole-2-one, manufacture and intermediate, use as drug and composition
NO951309L (no) Forbindelser for bruk som additiver i oljeholdige sammensetninger
JPS6426553A (en) Novel derivative of 1-benzyl-2-oxo-5-alkoxy- pyrrolidine, manufacture, use as drug and composition

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 526642

Country of ref document: ES